Search concepts
|
Selected filters
|
- 350 - 400 out of 6,888 results
- Export search results
Search results
-
Active
ActiveAI - active learning and selective attention for robust, transparent and efficient AI
Barron, A. & Philippides, A.
1/11/19 → 31/10/22
Project: Other
-
Skills articulation through visual narratives
Lin-Stephens, S. & Downes, J.
31/10/19 → 31/10/24
Project: Research
-
AGCMP - SMOC+ RisC: An Australian Genomic Cancer Medicine Program for Rare and Less Common Cancers
Thomas, D. M., Simes, J., Scott, C., Fox, S., Brown, M. P., Scott, H., Schofield, D., O'Byrne, K., Lakhani, S., Millward, M. & Young, R.
31/10/19 → 31/12/24
Project: Research
-
Music can speak for you: making music with a deep net partner
Dean, R. T., Hamilton, T., Walder, C., Davis, J. & Heble, A.
31/10/19 → 31/12/23
Project: Other
-
SWAN: Enhanced 3-D seismic structure for Southwest Australia
Miller, M., Kennett, B., Allen, T., Gray, S., Gessner, K. & Yuan, H.
30/10/19 → 29/10/22
Project: Other
-
TTVF: Transitioning Taranaki to a Volcanic Future
Turner, S. & Cronin, S. J.
28/10/19 → 31/03/24
Project: Research
File -
Two-day workshop and other setup cost of ARC Centre of Excellence in Synthetic Biology
25/10/19 → 24/10/21
Project: Other
-
Two-day workshop and other setup cost of ARC Centre of Excellence in Synthetic Biology
25/10/19 → 24/10/21
Project: Other
-
ADVANCE-outcomes 303: A phase 3 open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in subjects with World Health Organisation (WHO) Group 1 pulmonary arterial hypertension (PAH): ADP811-303
Brown, M., Butala, R. & Chapman, N.
17/10/19 → 30/06/22
Project: Research
-
ADVANCE-outcomes: A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH: APD811-301
Brown, M., Butala, R. & Chapman, N.
17/10/19 → 30/06/22
Project: Research
-
The Ties that Bind: Negotiating Foreign Relations in the Second Millennium BC
7/10/19 → 6/10/22
Project: Other
-
COSMIC: A randomized, double-blind, controled phase 3 study of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in subjects with previously untreated advanced or metastatic renal cell carcinoma of intermediate to poor risk
Gurney, H., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
2/10/19 → 11/07/24
Project: Other
-
COSMIC: A randomized, double-blind, controled phase 3 study of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in subjects with previously untreated advanced or metastatic renal cell carcinoma of intermediate to poor risk
Gurney, H., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
2/10/19 → 11/07/24
Project: Other
-
A dashboard of predictive analytics and decision support to drive care quality and person-centred outcomes in aged care
Westbrook, J., Georgiou, A., Lord, S. R., Gray, L., Day, R., Ratcliffe, J., Baysari, M. & Braithwaite, J.
1/10/19 → 30/09/24
Project: Research
-
GLPreAD: Genetic and lifestyle susceptibility and resilience factors affecting rates of change in preclinical Alzheimer's Disease
Laws, S., Villemagne, V., Hardy, J., Savage, G., Burnham, S. & Rainey-Smith, S.
1/10/19 → 30/09/22
Project: Other
-
Conjunction in Child Language
Koring, L., Hackl, M., Bill, C., Chen, S., Kobayashi, F. & Rosenstein, L.
1/10/19 → 1/07/21
Project: Research
-
TTVF: Transitioning Taranaki to a Volcanic Future
Cronin, S. J., Wilson, T., Brenna, M., Rushmer, T., Bebbington, M. S., McDonald, G., Turner, S., McCallion, A., Wang, T., Jolly, A., Wreford, A., Ukstins, I., Magill, C., Schipper, C. I. & Pardo, N.
1/10/19 → 30/09/24
Project: Research
-
A toolbox to underpin and enable tomorrow's marine biosecurity system
Floerl, O., Zaiko, A., Hopkins, G., Cahill, P., Pochon, X., Wood, S., Davidson, I., South, P., Vennell, R., Atalah, J., Newton, M., Smeaton, M., Gemmell, N., Stanton, J., Guen, M. J. L., Welsh, M., Yao, R., Treml, E., Dafforn, K., Badyal, J. P. & Chetham, J.
1/10/19 → 30/09/24
Project: Other
-
Active Implementation of Australian Consensus Guidelines for the Effective Delivery of Clinical Services to Patients with Mitochondrial Disorders
Christodoulou, J., Braithwaite, J., Long, J. & Best, S.
1/10/19 → 30/09/21
Project: Other
-
Harbour Biomed 4003.1: A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors
Gurney, H., Chapman, N., Butala, R., Parshionikar, A. & Rajasekharan Nair, A.
30/09/19 → 30/09/24
Project: Other
-
GALAXI: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
Leong, R., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
30/09/19 → 7/05/24
Project: Research
-
Disease susceptibility, precision medicine and ALS
Atkin, J., Blair, I., Rowe, D. & Lim, E.
30/09/19 → 30/09/21
Project: Other
-
All integrated mid-infrared fiber lasers
Fuerbach, A., Jackson, S., Withford, M. & Ebendorff-Heidepriem, H.
27/09/19 → 26/09/22
Project: Research
-
VEGA: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Leong, R., Butala, R. & Chapman, N.
24/09/19 → 11/07/24
Project: Other
-
LEAP-011: A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression: Protocol MK7902-011-00
Zhang, A., Butala, R. & Chapman, N.
13/09/19 → 6/06/24
Project: Research
-
KEYNOTE-905: A Phase 3 Randomized Study of Cystectomy plus Perioperative Pembrolizumab versus Cystectomy Alone in Cisplatin-ineligible Participants with Muscle-invasive Bladder Cancer (MK3475-905)
Zhang, A., Chapman, N. & Parshionikar, A.
13/09/19 → 6/06/24
Project: Other
-
Producing Knowledge in Precarity: research, universities and labour insecurity
10/09/19 → …
Project: Research
File -
Whole number and fraction magnitude understanding in kindergartners
Múñez, D., Cheung, P. & Bull, R.
2/09/19 → 30/11/21
Project: Research
-
Understanding the Links Between Hearing Impairment with Cognitive Decline and Dementia.
Dawes, P., Pendleton, N., Maharani, A., Elliott, R., Tampubolon, G. & Matthews, K.
1/09/19 → 30/09/22
Project: Research
-
Improving access to effective pain management: Reducing the burden of chronic pain for Australian adolescents
1/09/19 → 28/04/23
Project: Other
-
Towards optimal use of internet-delivered interventions for obsessive-compulsive disorder
Wootton, B., Karin, E., Titov, N. & Dear, B.
1/09/19 → 1/12/22
Project: Research
-
The cost and health impact of short-term health staffing in remote and rural Aboriginal and Torres Strait Islander communities: Does Community Control make a difference?
Wakerman, J., Humphreys, J., Dunbar, T., Bourke, L., Mulholland, E., Guthridge, S., Zhao, Y., Jones, M. & Boffa, J.
15/08/19 → 14/08/22
Project: Other
-
-
-
KEYNOTE-641: Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Gurney, H., Chapman, N. & Butala, R.
8/08/19 → 5/06/24
Project: Other
-
ARC Linkage: Beyond Speech: Towards better communication for children with hearing loss
Demuth, K., Sharma, M., Leigh, G., Kaltenbrunn, I., Davis, A., King, A., Brinson, M. & Lo, C.
8/08/19 → 31/12/22
Project: Other
-
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.
Zhang, A., Chapman, N. & Butala, R.
6/08/19 → 18/06/24
Project: Other
-
A Phase 1B, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination with Rucaparib in patients with Advanced Breast, Ovarian, or Prostate Cancer
Gurney, H., Chapman, N. & Butala, R.
5/08/19 → 26/06/24
Project: Other
-
OPTUS Roundtable: Digital risks, empahty and discrenment in an AI-powered world
5/08/19 → …
Project: Research
-
Empathetic capacity and human-robot interaction
Lajante, M., Tojib, D. & Ho, I.
5/08/19 → …
Project: Research
-
A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti-PD-L1 Antibody) in combination with adjuvant Anthracycline/Taxane-based Chemotherapy versus Chemotherapy Alone in patients with operable Triple-Negative Breast Cancer
Sabanathan, D., Kefford, R., Chapman, N. & Butala, R.
5/08/19 → 24/10/23
Project: Other
-
-
-
Not lone wolf: nurturing and valuing often hidden relationships in academic research practice.
Wright, S., Lloyd, K., Suchet-Pearson, S. & Daley, L.
1/08/19 → 1/10/21
Project: Research
-
A Multi-Factor Model of China's Security Strategy in East Asia
Lim, Y., Gill, B. & Liao, N. C.
31/07/19 → 30/07/21
Project: Other
-
-
The ecology of the newly described and endangered frog, Uperoleia mahonyi
Clulow, S., Webster, G. & Whiting, M.
29/07/19 → 31/12/21
Project: Other
-
-
The ecology of a newly described and endangered frog, Mahony's toadlet
Clulow, S. & Webster, G.
29/07/19 → 31/12/21
Project: Other